Doctor Anywhere bags $38.44m Series B funding

It plans to expand its platform to more markets this year.

Healthtech startup Doctor Anywhere has secured a $38.44m (US$27m) Series B financing round led by Australia-based Square Peg, EDBI, and IHH Healthcare, according to a press release.

The latest investment will help Doctor Anywhere prepare for an extensive expansion.

Rounding out this series of funding are Pavilion Capital and existing shareholder Kamet Capital, bringing Doctor Anywhere’s total capital base to exceed $56.95m (US$40m).

Doctor Anywhere recently launched its platform in Thailand. It also operates in Hanoi and Ho Chi Minh City, Vietnam, with announcements on other regional plans in the pipeline due later this year.

Aiming to provide means to manage health easily, Doctor Anywhere allows users to consult a licensed local doctor through its digital platform, and to get medication delivered to their doorsteps. Medical history, health reports, and other documents are stored in-app.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia